Related Experiment Video
Updated: May 18, 2026

04:25
Manual Segmentation of the Human Choroid Plexus Using Brain MRI
Published on: December 15, 2023
Association between choroid plexus enlargement and impaired glymphatic function in relapsing-remitting multiple
Lina Kong1, Zichun Yan1, Qiyuan Zhu1
1Department of Radiology, The First Affiliated Hospital of Chongqing Medical University, No. 1 Youyi Road, Yuzhong District, Chongqing 400016, China.
Brain Research Bulletin
|May 16, 2026
Summary
Multiple sclerosis patients show impaired glymphatic system function and enlarged choroid plexus. These changes correlate with disease severity and may offer new imaging biomarkers and therapeutic targets for MS.
Area of Science:
- Neuroscience
- Radiology
- Immunology
Background:
- The glymphatic system and choroid plexus (CP) roles in multiple sclerosis (MS) are not fully understood longitudinally.
- Relapsing-remitting MS (RRMS) involves complex pathological mechanisms.
- Understanding these changes is crucial for MS management.
Purpose of the Study:
- To characterize glymphatic system function and CP alterations in RRMS.
- To analyze their longitudinal evolution in RRMS.
- To examine correlations with clinical variables like white matter lesions.
Main Methods:
- Recruited 92 RRMS patients and 40 healthy controls (HCs).
- Utilized diffusion tensor imaging analysis along the perivascular space (DTI-ALPS) index and normalized choroid plexus volume (CPV).
- Compared DTI-ALPS and CPV between groups at baseline and follow-up, assessing correlations with lesion volume and disease duration.
Main Results:
- RRMS patients had significantly lower ALPS index and larger CPV than HCs.
- Lower ALPS index correlated with larger CPV, greater white matter lesion (WML) and cortical lesion volume, and longer disease duration.
- CPV increased slightly over time in RRMS patients, while ALPS index remained stable.
Conclusions:
- Impaired glymphatic function and enlarged CP volume are implicated in MS pathology.
- CP enlargement may be a persistent feature in MS.
- DTI-ALPS index and CP volume show potential as imaging biomarkers, with the CP as a therapeutic target.
Related Concept Videos
Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Cerebral Edema ll: Pathophysiology
Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
The Blood-brain Barrier
Overview
Increased Intracranial Pressure ll: Pathophysiology
Increased intracranial pressure (ICP) refers to a potentially life-threatening rise in pressure inside the skull. This usually happens when there is a major change in the volume of brain tissue, blood, or cerebrospinal fluid (CSF) — the three components inside the skull. According to the Monro-Kellie doctrine, if the volume of one component increases, the volumes of the other components must decrease to maintain normal pressure. If this does not happen, ICP rises.The process often begins with...

